Back to Trades
KIRSCH ARTHUR S
DirectorCIK 0001290976
Profile
- Filings
- 9
- Buy transactions
- 1
- Sell transactions
- 3
- Companies
- 3
- Active
- 2025–2026
Across 9 filings between 2025–2026, KIRSCH ARTHUR S, Director, has disclosed $4.6M in transactions — spread across 3 companies. Their disclosed trades are heavily weighted toward selling — $133.0K in buys and $1.7M in sells. The largest single open-market purchase on record is $133.0K in Evommune, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Nov 18 | LQDA Liquidia Corp | KIRSCH ARTHUR S | Director | Exercise | $363.0K |
| Nov 17 | EVMN Evommune, Inc. | KIRSCH ARTHUR S | Insider | Award | $1.3M |
| Jul 8 | EVMN Evommune, Inc. | KIRSCH ARTHUR S | Insider | Buy | $133.0K |
| Jun 23 | AVIR Atea Pharmaceuticals, Inc. | KIRSCH ARTHUR S | Insider | Award | $164.4K |
| Jun 18 | LQDA Liquidia Corp | KIRSCH ARTHUR S | Director | Grant | $0 |
| Jun 3 | EVMN Evommune, Inc. | KIRSCH ARTHUR S | Insider | Award | $310.6K |
| Jun 3 | LQDA Liquidia Corp | KIRSCH ARTHUR S | Director | Sell | $1.7M |
| Nov 7 | EVMN Evommune, Inc. | KIRSCH ARTHUR S | Insider | Award | $607.4K |
| Nov 5 | EVMN Evommune, Inc. | KIRSCH ARTHUR S | Insider | Other | $0 |
9 filings